Seattle-based biotech Vedana Therapeutics launched out of stealth Wednesday with a $46 million Series A round.
Backed by Amazon’s Housing Fund and Seattle Credit Union, the project will offer affordable homes near light rail while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results